Navigation Links
Precision Therapeutics President and CEO Sean McDonald Recognized as a Leading Business Executive and Recipient of 2010 Pacesetters Award
Date:9/22/2010

PITTSBURGH, Sept. 22 /PRNewswire/ -- Precision Therapeutics announced today that President and Chief Executive Officer Sean McDonald received the Smart Business Magazine 2010 Pacesetters Award.  The award honors thirteen regional Pacesetters and recognizes the impact of their influence in the community-at-large as well as within their own organizations. The event took place on Tuesday, September 21st at the Kean Theatre in The Washington Place, Gibsonia, Pennsylvania.  Mr. McDonald was recognized as a leader in the mid-sized company category who is setting the pace for the Pittsburgh region.

(Photo: http://photos.prnewswire.com/prnh/20100922/NE69963 )

(Photo: http://www.newscom.com/cgi-bin/prnh/20100922/NE69963 )

"Being named a Smart Business Pacesetter is such an honor for me and my team as we work toward our goal of optimizing each patient's quality of life and chance for survival by designing advanced technology that offers hope for personalized cancer treatment," said McDonald.  "It is great to see that Pittsburgh is receiving recognition as a leader in the growing life science industry and a privilege to be a part of that development."

McDonald joined Precision Therapeutics in 2001 and serves as President and CEO. Previously, Mr. McDonald founded Automated Healthcare in 1992, developing the first robotics-based solution to hospital pharmacy management.  Mr. McDonald grew the company to over $150 million in revenues when it was acquired by the McKesson Corporation in 1996.

About Precision Therapeutics

Precision Therapeutics, a life-science company based in Pittsburgh, Pennsylvania, is committed to improving outcomes of cancer patients.  As leaders in the science of individualizing cancer therapy through the use of a proprietary and unique live-tissue platform, Precision develops novel markers to help guide treatment decisions based on the biological processes of each individual's cancer.

Precision's state of the art bioinformatics combined with the analysis of the live molecular, proteomic and genomic activity of each patient's cancer offer an innovative foundation for further development and commercialization of novel predictive markers for cancer therapy.  Precision's first commercial test, ChemoFx®, is a proprietary drug response marker which measures an individual's malignant tumor response to a range of standard therapeutic alternatives under consideration by a physician.  For more information, please visit www.precisiontherapeutics.com

About Pacesetters

The Pacesetter Awards are designed to recognize business leaders in the Greater Pittsburgh Area who are setting the pace for the region.  Leaders are recognized in three divisions based on the size of their organization, its revenue and overall story of success and influence within the organization as well as the community at large.

For more information, please visit www.sbnonline.com.


'/>"/>
SOURCE Precision Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Clinical Experts Detail How They Use Varians TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments
2. Applied Precisions Mobile Imaging Lab Hits the Road for a Cross-Country Journey
3. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
4. Precision Bearing Technologies Featured at Atlantic Design & Manufacturing Show
5. Applied Precision Announces New Products for Life Sciences Microscopy at the 110th American Society for Microbiology Meeting in San Diego, CA, May 23-26th.
6. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
7. Echo Therapeutics Initiates Needle-Free Biosensor Program for Continuous Lactate Monitoring
8. Signum Biosciences Awarded Two Additional NIH Grants for Development of Topical Therapeutics
9. CoDa Therapeutics NEXAGON® Wound Healing Gel Named to Windhovers Top 10 HOT SPACE Projects to Watch
10. Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals
11. Echo Therapeutics to Present at Prestigious Accredited Members, Inc. Fall 2010 Small Cap/Micro Cap Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Research and Markets has announced the addition of the ... to 2021" report to their offering. ... , , The immunohistochemistry (IHC) ... a CAGR of 7.3% during the forecast period of 2016 to 2021. ... rapidly increasing geriatric population across the globe are the primary driving the ...
(Date:12/7/2016)... 7, 2016  Palatin Technologies, Inc. ("Palatin") (NYSE ... a previously disclosed underwritten public offering of units ... as sole book-running manager, Roth Capital Partners acted ... as co-manager for the offering. "This ... net proceeds, allowing us to continue advancing bremelanotide ...
(Date:12/7/2016)... , Dec. 7, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Janus Kinase 3 (JAK3) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... When it came time to blow out his candles on ... later, the Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his ... the hospital’s 30th heart transplant recipient. , “He was playing at home, when we ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... financial consultation services to residents in the Sacramento/Folsom region, is initiating a charity ... facility. , The Another Choice Another Chance treatment center in Sacramento works to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... AlignLife clinics nationwide ... Many children are not fortunate enough to receive bountiful gifts wrapped tightly under a ... can bring to the children of the world. , In exchange for generous donations, ...
(Date:12/7/2016)... OR (PRWEB) , ... December 07, 2016 , ... Sharon ... Water, Global Climate Change and Your Health on Voice of America, declared on her ... to call attention to the fact that when these bullies attack leaders in corporate ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers ... Season. Save Up To 33% Off Botox® and Juvederm® Products Now Through December 31, ... with Delightful Deals on Botox® and Juvederm® just in time for the ...
Breaking Medicine News(10 mins):